Viewing Study NCT04497961


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2025-12-29 @ 1:34 PM
Study NCT ID: NCT04497961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-11
First Post: 2020-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module